Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to -$20.5 million.

  • Astera Labs' Gains from Investment Securities changed N/A to -$20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $500000.0, marking a year-over-year decrease of 9764.66%. This contributed to the annual value of $20.1 million for FY2024, which is 71190.96% up from last year.
  • Latest data reveals that Astera Labs reported Gains from Investment Securities of -$20.5 million as of Q3 2025.
  • In the past 5 years, Astera Labs' Gains from Investment Securities ranged from a high of $20.1 million in Q1 2024 and a low of -$20.5 million during Q3 2025
  • For the 3-year period, Astera Labs' Gains from Investment Securities averaged around $3.8 million, with its median value being $1.2 million (2023).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 139858.42% in 2024, then tumbled by 9490.33% in 2025.
  • Over the past 3 years, Astera Labs' Gains from Investment Securities (Quarter) stood at $1.1 million in 2023, then surged by 1671.89% to $20.1 million in 2024, then crashed by 201.78% to -$20.5 million in 2025.
  • Its Gains from Investment Securities was -$20.5 million in Q3 2025, compared to $19.9 million in Q2 2025 and $1.0 million in Q1 2025.